Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/head.13810 http://scihub22266oqcxt.onion/10.1111/head.13810 32227596!7228371!32227596     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Headache 2020 ; 60 (5): 833-842 Nephropedia Template TP {{tp|p=32227596|t=2020. Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers |pdf=|usr=}}{{32227596}} gab.com Text Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers JO: Headache http://www.kidney.de/pget.php?&tw=1&pmid=32227596 #FOAvip OBJECTIVE: To outline strategies for the treatment of migraine which do not require in-person visits to clinic or the emergency department, and to describe ways that health insurance companies can remove barriers to quality care for migraine. BACKGROUND: COVID-19 is a global pandemic causing widespread infections and death. To control the spread of infection we are called to observe "social distancing" and we have been asked to postpone any procedures which are not essential. Since procedural therapies are a mainstay of headache care, the inability to do procedures could negatively affect our patients with migraine. In this manuscript we review alternative therapies, with particular attention to those which may be contra-indicated in the setting of COVID-19 infection. DESIGN/RESULTS: The manuscript reviews the use of telemedicine visits and acute, bridge, and preventive therapies for migraine. We focus on evidence-based treatment where possible, but also describe "real world" strategies which may be tried. In each section we call out areas where changes to rules from commercial health insurance companies would facilitate better migraine care. CONCLUSIONS: Our common goal as health care providers is to maximize the health and safety of our patients. Successful management of migraine with avoidance of in-person clinic and emergency department visits further benefits the current urgent societal goal of maintaining social distance to contain the COVID-19 pandemic. Twit Text FOAVip Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers ????Headache http://www.kidney.de/pget.php?&tw=1&pmid=32227596 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32227596 #FOAvip English Wikipedia <ref>{{Cite pmid|32227596}}</ref> Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers #MMPMID32227596 Szperka CL; Ailani J; Barmherzig R; Klein BC; Minen MT; Halker Singh RB; Shapiro RE Headache 2020[May]; 60 (5): 833-842 PMID32227596show ga OBJECTIVE: To outline strategies for the treatment of migraine which do not require in-person visits to clinic or the emergency department, and to describe ways that health insurance companies can remove barriers to quality care for migraine. BACKGROUND: COVID-19 is a global pandemic causing widespread infections and death. To control the spread of infection we are called to observe "social distancing" and we have been asked to postpone any procedures which are not essential. Since procedural therapies are a mainstay of headache care, the inability to do procedures could negatively affect our patients with migraine. In this manuscript we review alternative therapies, with particular attention to those which may be contra-indicated in the setting of COVID-19 infection. DESIGN/RESULTS: The manuscript reviews the use of telemedicine visits and acute, bridge, and preventive therapies for migraine. We focus on evidence-based treatment where possible, but also describe "real world" strategies which may be tried. In each section we call out areas where changes to rules from commercial health insurance companies would facilitate better migraine care. CONCLUSIONS: Our common goal as health care providers is to maximize the health and safety of our patients. Successful management of migraine with avoidance of in-person clinic and emergency department visits further benefits the current urgent societal goal of maintaining social distance to contain the COVID-19 pandemic. |*Pandemics[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Insurance, Health[MESH] |Migraine Disorders/*therapy[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Telemedicine[MESH]Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insu(epmc).pdf DeepDyve Pubget Overpricing